Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2026-02-26 @ 8:12 PM
Study NCT ID:
NCT03276156
Status:
UNKNOWN
Last Update Posted:
2017-09-08
First Post:
2017-09-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer
Sponsor:
Zhejiang Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Ahead-G001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |